David S. Grierson

5.0k citations

138 papers · 3.8k indexed · h-index 34

Organic Chemistry top 0.5%
Molecular Biology top 5%
Infectious Diseases top 5%
Materials Chemistry
Pulmonary and Respiratory Medicine top 10%

Co-authors: Michel Legraverend Henri Philippe Husson Florence Mahuteau‐Betzer Henri‐Philippe Husson Martin Harris Sandrine Piguel Jacques Royer François Besselièvre
Topics: HIV/AIDS drug development and treatment (30 papers)HIV Research and Treatment (20 papers)Asymmetric Synthesis and Catalysis (18 papers)
Cited by: Organic Chemistry Virology Molecular Biology
Journals: Journal of the American Chemical Society Nucleic Acids Research The Journal of Cell Biology
Partner nations: France Canada Spain

In The Last Decade

David S. Grierson

135 papers receiving 3.7k citations

Peers

Countries citing papers authored by David S. Grierson

Since Specialization

Citations

This map shows the geographic impact of David S. Grierson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Grierson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Grierson more than expected).

Fields of papers citing papers by David S. Grierson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Grierson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Grierson. The network helps show where David S. Grierson may publish in the future.

Co-authorship network of co-authors of David S. Grierson

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Grierson. A scholar is included among the top collaborators of David S. Grierson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Grierson. David S. Grierson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response 2024 ·Oncotarget ·Lulzim Shkreta,Johanne Toutant,(unknown),David Durantel,Anna Salvetti,Sophie Ehresmann,Martin Sauvageau,(unknown),(unknown),(unknown),Caroline Huard,Jasmin Coulombe‐Huntington,Mike Tyers,David S. Grierson,Pierre‐Luc Boudreault,Benoı̂t Chabot	2
2	Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood–Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases 2018 ·Journal of Medicinal Chemistry ·Ronan Gealageas,(unknown),(unknown),(unknown),(unknown),(unknown),Markus Heller,Verena Goebeler,(unknown),David S. Grierson,Edward E. Putnins	14
3	Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication 2016 ·Nucleic Acids Research ·Lulzim Shkreta,Marco Blanchette,Johanne Toutant,Emmanuelle Wilhelm,Brendan Bell,(unknown),(unknown),Alan Cochrane,Peter K. Cheung,P. Richard Harrigan,David S. Grierson,Benoı̂t Chabot	35
4	Protection against Retrovirus Pathogenesis by SR Protein Inhibitors 2009 ·PLoS ONE ·Anne Keriel,Florence Mahuteau‐Betzer,Chantal Jacquet,(unknown),David S. Grierson,Marc Sitbon,Jamal Tazi	16
5	Salicylaldehyde Derivatives as New Protein Kinase CK2 Inhibitors 2008 ·HAL (Le Centre pour la Communication Scientifique Directe) ·(unknown),(unknown),(unknown),Caroline Barette,David S. Grierson,(unknown),Jean‐Claude Florent,Laurence Lafanéchère,Frédéric Schmidt,Claude Cochet	11
6	Small-Molecule Inhibition of HIV pre-mRNA Splicing as a Novel Antiretroviral Therapy to Overcome Drug Resistance 2007 ·PLoS Pathogens ·(unknown),Yea‐Lih Lin,(unknown),Lilia Ayadi,Florence Mahuteau‐Betzer,Chi Hung Nguyen,Clément Mettling,Pierre Portalès,David S. Grierson,Benoı̂t Chabot,Philippe Jeanteur,Christiane Branlant,Pierre Corbeau,Jamal Tazi	71
7	In vitro phototoxicity of glycoconjugated porphyrins and chlorins in colorectal adenocarcinoma (HT29) and retinoblastoma (Y79) cell lines 2007 ·Photodiagnosis and Photodynamic Therapy ·Ph. Maillard,Bernard Loock,David S. Grierson,Isabelle Laville,J. Blais,François Doz,Laurence Desjardins,Danièle Carrez,Jean‐Luc Guerquin‐Kern,Alain Croisy	42
8	The purines: Potent and versatile small molecule inhibitors and modulators of key biological targets 2006 ·Bioorganic & Medicinal Chemistry ·Michel Legraverend,David S. Grierson	288
9	Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat 2006 ·Journal of Photochemistry and Photobiology B Biology ·(unknown),(unknown),C. Lamotte,(unknown),Daniel Auchère,Robert Farinotti,Philippe Maillard,David S. Grierson,P. Prognon,Athéna Kasselouri	16
10	Structure–activity relationship in the 3-iodo-4-phenoxypyridinone (IOPY) series: The nature of the C-3 substituent on anti-HIV activity 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Jérôme Guillemont,Élisabeth Pasquier,(unknown),Koen Andries,Chi Hung Nguyen,David S. Grierson	13
11	A Pd(0) based cross-coupling approach to the synthesis of 2-amidopurines and their evaluation as CDK inhibitors 2006 ·Bioorganic & Medicinal Chemistry ·(unknown),Michel Legraverend,(unknown),Olivier Lozach,Laurent Meijer,David S. Grierson	17
12	Benzoquinoquinoxaline Derivatives Stabilize and Cleave H-DNA and Repress Transcription Downstream of a Triplex-forming Sequence 2005 ·Journal of Molecular Biology ·Hamzeh Amiri,Natalia Nekhotiaeva,Jian‐Sheng Sun,Chi-Hung Nguyen,David S. Grierson,Liam Good,Rula Zain	16
13	A study of the stability of tri(glucosyloxyphenyl)chlorin, a sensitizer for photodynamic therapy, in human colon tumoural cells: a liquid chromatography and MALDI-TOF mass spectrometry analysis 2004 ·Bioorganic & Medicinal Chemistry ·Isabelle Laville,(unknown),(unknown),(unknown),Bernard Loock,Ph. Maillard,David S. Grierson,J.C. Blais	31
14	Enhanced detection of seven glucoconjugated and hydroxylated porphyrins and chlorins by nonaqueous capillary electrophoresis combined with stacking 2004 ·Journal of Chromatography A ·Florentina Cañada Cañada,Athéna Kasselouri,P. Prognon,Philippe Maillard,David S. Grierson,Stéphanie Descroix,Myriam Taverna	21
15	Triple‐Helix Directed Cleavage of Double‐Stranded DNA by Benzoquinoquinoxaline‐1,10‐phenanthroline Conjugates 2004 ·ChemBioChem ·Ahmed Zaid,Jian‐Sheng Sun,(unknown),Émile Bisagni,Thérèse Garestier,David S. Grierson,Rula Zain	31
16	Optimization of Triple‐Helix‐Directed DNA Cleavage by Benzoquinoquinoxaline–Ethylenediaminetetraacetic Acid Conjugates 2003 ·ChemBioChem ·Rula Zain,(unknown),(unknown),Y. Blouquit,Émile Bisagni,Thérèse Garestier,David S. Grierson,Jian‐Sheng Sun	9
17	Synthesis, cellular internalization and photodynamic activity of glucoconjugated derivatives of tri and tetra(meta-hydroxyphenyl)chlorins 2003 ·Bioorganic & Medicinal Chemistry ·Isabelle Laville,Tamiris Vilas Boas Figueiredo,Bernard Loock,(unknown),Ph. Maillard,David S. Grierson,Danièle Carrez,Alain Croisy,J. Blais	106
18	“Mixed Inhibitors” of HIV-Reverse Transcriptase: Synthesis and Antiviral Activity 1999 ·Nucleosides and Nucleotides ·Renée Pontikis,Reine Note,(unknown),(unknown),(unknown),David S. Grierson,Claude Monneret	1
19	Intramolecular Diels−Alder Reaction of 2-Cyano-1-aza-1,3-butadienes 1997 ·The Journal of Organic Chemistry ·(unknown),(unknown),David S. Grierson,Frank W. Fowler	52
20	N- versus O-Alkylation of 2,3'-anhydrothymidine: reaction of the obtained pyrimidinium salts with azide ion 1993 ·The Journal of Organic Chemistry ·(unknown),David R. Adams,A. Chiaroni,C. Riche,David S. Grierson	10

About David S. Grierson

David S. Grierson is a scholar working on Virology, Organic Chemistry and Infectious Diseases, having authored 138 papers that have together received 3.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (30 papers), HIV Research and Treatment (20 papers) and Asymmetric Synthesis and Catalysis (18 papers). The work is most often cited by research in Organic Chemistry (2.4k citations), Virology (237 citations) and Molecular Biology (1.4k citations). David S. Grierson has collaborated with scholars based in France, Canada and Spain. Frequent co-authors include Michel Legraverend, Henri Philippe Husson, Florence Mahuteau‐Betzer, Henri‐Philippe Husson, Martin Harris, Sandrine Piguel, Jacques Royer, François Besselièvre, Frank W. Fowler and Luc Guerrier. Their work appears in journals such as Journal of the American Chemical Society, Nucleic Acids Research and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact